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The involvement of cancer patients in the four stages of decision-
making preceding continuous sedation until death. A qualitative 
study. 
 
ABSTRACT 
Background: Involving patients in decision-making is considered to be particularly appropriate 
towards the end of life. Professional guidelines emphasize that the decision to initiate 
continuous sedation should be made in accordance with the wishes of the dying person and be 
preceded by their consent. 
Aim: To describe the decision-making process preceding continuous sedation until death with 
particular attention to the involvement of the person who is dying. 
Design: Qualitative case studies using interviews. 
Setting/participants: Interviews with 26 physicians, 30 nurses and 24 relatives caring for 24 
patients with cancer who received continuous sedation until death in Belgium, UK, and the 
Netherlands. 
Results: We distinguished four stages of decision-making: initiation, information exchange, 
deliberation and the decision to start continuous sedation until death. There was wide variation 
in the role the patient had in the decision-making process. At one end of the spectrum (mostly in 
UK), the physician discussed the possible use of sedation with the patient, but took the decision 
themselves. At the other end (mostly in BE and NL), the patient initiated the conversation and 
the physicianǯs role was largely limited to evaluating if and when the medical criteria were met.  
Conclusions: Decision-making about continuous sedation until death goes through four stages 
and the involvement of the patient in the decision-making varies. Acknowledging the potential 
sensitivity of raising the issue of end-of-life sedation, we recommend building into clinical 
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practice regular opportunities to discuss the goals and preferences of the person who is dying 
for their future medical treatment and care. 
Keywords: Patient participation Ȃ decision making Ȃ patient centred care Ȃ continuous sedation 
until death Ȃ palliative sedation Ȃ qualitative research 
KEY STATEMENTS 
What is already known about the topic? 
x Involving patients in making decisions about their own treatment and care has been 
recognized as a cornerstone of person-centred care and is considered to be particularly 
appropriate towards the end of life because end-of-life decisions are probably even more 
preference-sensitive. 
x Up to now, most studies on the involvement of patients in treatment decision-making are 
conducted in a curative setting, where patients often have to choose between two 
treatments that have both proven to be effective. However, it is not known to what 
extent the choices and preferences of patients are taken into account in end-of-life 
decision-making when cure is no longer possible. 
What this paper adds 
x This study enhances understanding in end-of-life decision-making by making use of  
Charles et al model of treatment decision-making that allowed us to scrutinize the 
different phases of decision-making and apply them to the process of continuous 
sedation. 
x Decision-making about continuous sedation until death goes through four stages and the 
use of sedation is preceded by two types of decision: the decision about whether to use 
sedation and the decision about when to start sedation. 
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x Although the overarching goal of continuous sedation at the end of life was similar in all 
cases, there was considerable variation in the timing and the role played by the patient 
in the decision-making in the countries studied.  
Implications for practice, theory or policy 
x Our findings point to the need to regularly discuss with people who are dying their goals 
and preferences regarding future medical care and treatment. 
x Future research should further unravel how patient preferences are elicited in actual 
encounters and what consequences this may have for the chances of the person who is 
dying participating in decision-making about the ending of their own life. 
1. INTRODUCTION 
Patient participation in decision-making is considered to be particularly appropriate towards 
the end of life because end-of-life decisions are often preference-sensitive (1Ȃ4). Studies have 
suggested that although a majority of people with limited life expectancy prefer a shared or 
active role in decision-making, their physicians and those close them are frequently unaware of 
their preferences (5Ȃ7). One of the most debated end-of-life practices is palliative sedation, 
particularly when it is used continuously until death (8Ȃ11). It entails the use of medication 
intended to induce a state of decreased consciousness until death to relieve the burden of 
symptoms that cannot be controlled adequately by conventional palliative treatment (12,13). 
Guidelines emphasize that the decision to initiate sedation should be made in accordance with 
the wishes of the patient and be preceded by their consent or the consent of a surrogate 
decision-maker if they lack decision-making capacity (12,14,15). Empirical studies have shown, 
however, that patient consent is not always obtained or sought (16,17).  
Previous research has shown that continuous sedation until death is practiced differently in 
different countries. The international UNBIASED study (18,19) showed that in the UK the use of 
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sedation is typically described as a gradual process involving increasing the dose in the context 
of symptom management, rather than as a deliberate planned event. In contrast, Belgian 
clinicians predominantly described it as an act of deep sedation from the start, emphasizing the 
importance of it being in response to a patient's request. Dutch clinicians emphasized that its use 
was a medical decision informed by the patient's wishes after establishing the presence of a 
refractory symptom. This suggests that both the practice of and the decision-making leading up 
to continuous sedation, and the extent to which the choices and preferences of patients are 
taken into account, may differ between countries. This study describes the decision-making 
process surrounding continuous sedation at the end of life in Belgium, the Netherlands and the 
United Kingdom, with particular attention to the role of patients.  
2. METHODS 
This study is part of the UNBIASED project undertaken in the United Kingdom (UK), the 
Netherlands (NL) and Belgium (BE) and involved in-depth interviews with physicians, nurses 
and ǯrelatives (18,20Ȃ23). The study was approved by research ethics committees as 
follows: 
- United Kingdom: Leicestershire, Northampton and Rutland Research Ethics Committee 
1, 10/H0406/57 
- Belgium: Ghent University Hospital Ethics Committee, B670201010174 
- The Netherlands: Erasmus MC Medical Ethical Research Committee, NL33327.078.10, 
v03. 
2.1. Settings 
To enable maximum variation in the cases studied, we explored the care of cancer patients who 
died in hospitals (oncology wards), palliative care units (PCU) (in Belgium) or hospices (in the 
UK and the Netherlands), and in the community (at home). 
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2.2. Participants and inclusion criteria for decedents 
In all countries, senior clinical staff members identified eligible decedents: patients aged over 18 
who had died of cancer and to whom sedating medications were administered continuously with 
the intention of decreasing awareness to alleviate otherwise uncontrollable symptoms (either 
physical or psychological/existential), and for whom the sedation was in place at the time of 
death. Nurses and physicians were invited to take part if they had been closely involved in the 
care of these patients and were interviewed about no more than three cases. If more than one 
physician or nurse was involved, all were interviewed where possible. Relatives were invited to ǯ
physician. Interviews took place as soon as possible after death, i.e. within 12 weeks, to 
maximize recall. This paper involves all complete cases (with at least one physician, one nurse 
and one relative interviewed) in order to obtain a comprehensive insight into the decision-
making process.  
2.3. Procedures 
Interviews were semi-structured using an aide mémoire. Interviews focused on recollections of 
the care of the decedent, reasons for the use of sedation, its implementation and decision-
making. Each participant gave written informed consent before taken part. The interviews were 
undertaken by trained interviewers and lasted approximately 60 minutes. Physicians and nurses 
could use the patient records if necessary to support them in their recollections but were asked 
to provide relevant information about the case in an anonymous manner. Interviews were audio 
recorded, transcribed and translated as required. Data collection was completed by the end of 
2012. 
2.4. Analysis 
Qualitative analysis software (NVIVO 11) was used to organize the data. The coding procedure of 
the interviews strictly followed the methods of qualitative content analysis. A combined model 
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of inductive and deductive coding was used, where deductive coding was based on the Charles et 
al (24) key model of treatment decision-making (TABLE 1). Qualitative analysis software 
(NVIVO 11) was used to organize the data. Three researchers (LR, KC and JR) independently 
analysed a first set of transcripts for concepts that were directly linked to the patientǯs 
preferences for sedation and their role in decision-making. The codes were compared and 
discrepancies were discussed until agreement was reached. A coding tree was developed by LR, 
KC, LD and JR, and agreed upon with all co-authors. All interviews were coded and quotes were 
selected on the basis of their being representative of the wider data and approved by all 
researchers. We followed the COREQ guidelines in reporting this study to ensure rigour in our 
research (25). 
3. RESULTS 
We studied all 24 complete patient cases (7 UK; 7 BE; 10 NL), involving interviews with 26 
physicians (9 UK; 7 BE; 10 NL), 30 nurses (10 UK; 10 BE; 10 NL), and 24 relatives (7 UK; 7 BE; 10 
NL). Table 2 provides an overview of the characteristics of the patients. Table 3 gives 
characteristics of the interviewees, showing that the majority of the clinicians (36 out of 56) 
were palliative care or hospice practitioners. Besides the three stages of decision-making as 
described in the model of Charles (24) (TABLE 1),  the initiation phase was added as it was 
important to understand who initiated or raised the possibility of sedation. We were therefore 
able to distinguish four stages of decision-making: (1) the initiation phase to understand who 
initiated or raised the possibility of sedation; (2) the exchange of all necessary information; (3) 
the deliberation phase in which it was decided to use continuous sedation when necessary and 
(4) the decision to actually begin it. Table 4 gives an overview of the characteristics of the 
decision-making process in all three countries. 
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3.1. Initiating the conversation  
The initiation phase appeared to be an interplay between the medical team and the patient and 
could best be understood as a continuum with, at the extremities, the initiative driven 
predominantly either by the patient or by the physician. When patients initiated it, they did so 
by indicating that their suffering had become unbearable and they no longer wanted to, or could, 
continue their treatment or even their life. Patients expressed this by using such phrases as ǮǯǡǮǯǡǮǯǮǯǤs expressed more 
explicit requests Ǯǯor tǮǯ. When a patient was no longer able to 
communicate, in all countries it was often the family who expressed what they believed to be the 
patientǯs preferences.  
In Belgium and the Netherlands, some patients requested euthanasia. This was often the starting 
point of a conversation about end-of-life preferences and the possible use of sedation.  
ǲ  life and I found it difficult to start talking about it. And 
ǡǡ ǡ ǯǡ ǡ 
euthanasia. Well a week passed and then Dr X came here, and then he discussed palliative sedation, 
ǯǤǤǤǤǳ (the Netherlands, 
Case 12, Home, Relative). 
In other situations, physicians initiated the conversation about the possible use of sedation, for 
instance when an acute exacerbation of symptoms that could not be managed in any other way 
was expected. During the course of the disease, physicians repeatedly discussed with the patient 
whether they Ǯǯor if they could Ǯbear the painǯǤNurses also had an important 
role in initiating discussion about the possible use of sedation.   
ǲǡǡ
ǯȏǥȐthe life expectancy 
suddenly becomes very short. He was in pain and he constantly sick, so he met the criteria of 
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palliative sedation. And that possibility was therefore discussed at that moment. ȏǥȐThey always 
were very difficult conversations because he did not really want to address those really big issuesǳ
(the Netherlands, Case 36, Community, Physician). 
3.2. Information exchange 
Once the conversation was initiated, it was usually the physician who summarized the situation 
and provided information to the patient and family. We distinguished two types of decision-
making. In the first, mainly in the Netherlands and Belgium, the physician had a predominantly 
informative role, informing the patient about their disease progression and the possibility of 
using sedation and the circumstances under which it could be used. They then either hoped to 
come to a shared decision by further exploring the preferences of the patient or they left it to the 
patient to make an informed decision themselves. Where desired, these physicians gave advice             ǯ
specific requests and wishes or the fact that the final choice should lie with the patient, provided 
that the clinical conditions were fulfilled. 
ǲpretended for a long time that everything was alright. But certainly the sedation was discussed 
towards the end, because what I can remember is that we did make the offer to him, like, to go to 
sleep, at a time when it would be ǳȋrlands, Case 21, Hospice, Physician). 
In the second type of situation, mainly in the UK, the physician took the lead by proposing the 
possible use of palliative sedation to control symptoms and to relieve terminal suffering. In these 
cases they aimed mainly to provide all the necessary information and then eventually to obtain 
the informed consent of the patient and/or the family. 
ǲTǥat ǡǡǮǡǯ
give him this drug that will help to ǡǯǥ that he can rest easy and 
ǯsǯǳȋǡ ?ǡǡȌǤ 
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3.3. Deliberation and the decision to use continuous sedation until death 
In all three countries, the possible use of sedation was usually discussed between the person 
who was dying, those close to them and the professional caregivers, which ultimately led to the 
consent and/or decision to use sedation. In some cases there were difficulties in coming to a 
decision. This happened particularly in situations where patients or their relatives Ǯ to ǯ Ǯwere ǯ Ǯǯ. For example, although one patient (UK, case 2, Hospice) was according to 
the physician clearly in the dying phase, his wife was Ǯǯ and worried about him Ǯǯ.  
 
ǲȋȌǡǡǡ his 
wife was not coping, she was devastated at the idea that we were gonna knock him out, or put him 
to sleep, and ǯǤȏǥȐ
Ǥǡǯsessed him later on that actually he was 
needing that. And her distress was understandable and was difficult, but I think, by the time I saw 
ǡ  ǯǡǡ  ǥǯ ȋǡ  ?ǡ
Hospice, Physician). 
 
In Belgium and the Netherlands the discussion sometimes specifically focussed on the Ǯǯ
between palliative sedation and euthanasia.  
 
ǲ             Ǥ   
from how the patient t       Ǯ I go to the euthanasia, or 
there I will go to palliative sedation.ǯ And I had well informed her about it and she has consciously 
ǳȋǡ ? ?ǡǡȌǤ 
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In cases of disagreement between patients and their relatives, physicians and nurses attempted 
to reconcile the two views. If this eventually proved impossible, physicians emphasized the 
importance of following the patientǯwishes ǮǯǤ  
 
3.4. Decision phase - the moment to start continuous sedation until death 
The involvement of patients in this phase was dependent whether the person who was dying 
was considered to have the capacity to take part in the final stages of the decision-making 
process or not. When competent, it was either they or the medical staff who took the final 
decision to begin palliative sedation. Patients in Belgium and the Netherlands indicated their 
readiness for the use of sedation in the later phases by using phrases such as Ǯit should happen ǯǮǯǤ  
 
ǲǮǡǤ 
ǮǫǯǮǡǯȗȗȗǮǯǤe 
Ǯǯ
soon as possibleǯǳȋǡ ?ǡǡȌǤ 
 
Patients were often unable to contribute to the decision to commence continuous sedation 
either because of an acute exacerbation of symptoms, which is what had necessitated the use of 
sedation, or because they were very close to death and had already lost the capacity to 
participate in the decision-making. Where the physician initiated the use of sedation, the 
decision had generally been taken at an earlier phase in anticipation of the moment when 
suffering would become unbearable. Some health care staff, mostly in the Netherlands, pointed 
out that the decision to commence continuous sedation is in the end a medical decision that 
physicians could take only Ǯinevitableǯ.  
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ǲIn some cases ȏǥȐyou see the patient is deteriorating and more and more medication is needed. 
Then a stage comes where you do talk with each other about gosh what are we going to do next? 
Patients do generally put that forward themselves, but it remains a medical decision that always 
lies with the doctor. And it may very well be that the doctor does not agree with the request of the 
patient, for the simple reason that there are no refractory symptoms or other cases ȏǥȐǳ ȋ
Netherlands, Case 12, Community, Nurse). 
 
In contrast, most health care staff in the UK pointed to a gradual progression without a 
particular moment of decision-making.   
 
ǲ always start in a cautious way and build up rather than starting with a high dose and 
completely flattening somebody at the outset, and that can sometimes be difficult. ȏǥȐThe family 
need to know that the intention is to review regularly and to be able to give an extra dose if 
ǳȋǡ ?ǡ Hospice, Physician). 
 
In other situations, family members had requested the use of sedation. For example, this was the 
case for a 30-year old man with a melanoma who died in a Belgian hospital (Case 12). The 
patient had earlier told his wife that he wanted to die Ǯin his sleepǯlost capacity 
and was suffering too much she was to instruct the doctor to start the sedation. That is what 
eventually happened.  
 
ǲǣ when you see that I am suffering too much, then you have to tell 
them that they should administer that. If I have to die, I rather die in my sleep he said because I do 
not... That he must not feel it.ǳȋǡ ? ?ǡǡȌ. 
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4. DISCUSSION AND CONCLUSION 
4.1. Main findings 
This study distinguishes four stages of decision-making: the initiation phase where the issue is 
raised, the exchange of all necessary information, the deliberation phase in which it is decided to 
use continuous sedation when it becomes appropriate, and the decision to begin continuous 
sedation. Although the overarching goal of continuous sedation at the end of life was similar in 
all cases, there was considerable variation in the timing and the role played by the patient in the 
decision making. At one end of the spectrum, decision-making was primarily clinical and 
physician-driven; the physician discussed the possible use of sedation with the patient but took 
the final decision him/herself. These cases were especially prevalent in the UK, where 
respondents reported a gradual process of sedation, from the provision of low doses of sedatives 
to the more rarely used continuous deep sedation. At the other end of the spectrum, the patient 
initiated the conversation about the use of sedation while the physicianǯs role was 
predominantly limited to evaluating whether, and when, the patientǯ  fulfilled the 
medical criteria. These cases were mostly from Belgium and the Netherlands, where patients 
were Ǯǯof sedation.  
4.2. Strengths and limitations 
The validity of this study was increased by deliberately sampling cases from three different care 
settings and three different countries using standardised criteria including a descriptive 
definition of the practice that was studied. In order to get a broad and detailed overview of each 
case, we included the recollections of physicians, nurses and relatives involved in the care of a 
particular person. Since preferences can change during the decision-making process, a 
retrospective assessment takes this possibility into account. Another strength is that we used 
the model of Charles et al (24) which allowed us to scrutinize the different phases of decision-
making and apply them to the process of continuous sedation, which is unprecedented. 
Limitations to this study should also be acknowledged. Our interview data was dependent on the 
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subjective experiences and interpretations of the respondents. There is a small risk of recall bias, 
though this was limited in most of the cases by limiting the time between death and the 
interview to three months.  
4.3. Discussion 
A theoretical framework such as that of Charles et al (24) seems useful in exploring end-of-life 
decision-making, showing there are several approaches to the initial decision to start continuous 
sedation. Decision-making in all phases could be described as being paternalistic, shared or 
informed, but it sometimes changed between the different phases. For example, in some cases 
the physician began the process with an informative approach but eventually took charge of the 
final decision to begin continuous sedation. Other studies have not described the decision-
making process in such detail. In our study, the possible use of continuous sedation was usually 
discussed with all parties and ultimately led to the consent and/or decision to use sedation if 
necessary. The information exchange and deliberation phases in our study closely match the 
three-step model for shared decision-making for clinical practice developed by Elwyn and 
colleagues (26)ǡ        Ǯ ǯ (making sure that 
patients know that different    Ȍǡ Ǯ ǯ ȋ 
detailed information about the Ȍ  Ǯ ǯ ȋ  
deciding what is best). From the results of this study, it is possible to distinguish two types of 
decision, the decision about whether to use sedation and the decision about when to start 
sedation. In both types, respondents placed high value on the ǯ, respecting 
their wishes, giving them explicit information about the implications and obtaining their 
consent.(27) However, this is far from always the case. A recent Belgian population-based death 
certificate study showed that the decision to use continuous sedation was in 16.2% of all cases 
made without a request from or the consent of the person who was dying or their  family.(17) 
Though clinical guidelines aim to support physicians in their decision-making and to promote 
best practice (e.g. the EAPC guideline for palliative sedation strongly encourages physicians to 
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Ǯaddress end-of-life care preferences with all patients at risk of dyingǯ prior to sedation and to 
obtain their consent (12,14,15) they rarely state the extent to which patient preferences should 
be taken into account, and how to deal with a patientǯs request for sedation. They do stress, 
however, the need for clinical indications for the use of sedation; in cases where this is the 
refractoriness of symptoms, a medical assessment by a clinical expert is required.(12) Some 
guidelines and frameworks, like the Dutch and Belgian ones, add to this that continuous sedation 
can only be used in the context of unbearable suffering, judged primarily by the patient him or 
herself, something that was often reflected in the Belgian and Dutch cases in our study. Belgian             ǯ
request for relief of suffering, provided that the clinical conditions were fulfilled. In both 
countries, patients were sometimes provided with the choice between sedation and euthanasia 
(which is legal, provided due care criteria are met). Thus, although respondents frequently used 
terms related to key indications for continuous sedation, and the decision to begin it was guided 
mainly by the clinical condition of the patient, it can be hypothesized that interviewees in all 
three countries expressed views that may corresponded to medico-cultural and societal 
perspectives on the practice of sedation. Different concepts of what sedation should be used for 
and how it should be practiced may have framed the ways in which a patientǯs preferences were 
elicited and the roles they were given in the decision-making process. Thus the focus of decision-
making seems to shift from the physician-centred medical criterion (refractoriness) in the UK to 
a more patient-centred perspective in Belgium and the Netherlands, where more emphasis is on 
the unbearableness of symptoms experienced by patients.(28)  It could be argued that in 
countries where euthanasia or physician-assisted suicide (PAS) are legal, open discussion of 
these and other ethically difficult end-of-life issues (28,29) allows patients,  their relatives and 
their physicians to be more open about discussing palliative sedation.(30) Future research 
should further develop the evidence base for the role of legal and cultural context on end-of-life 
decision-making and should further focus on the effectiveness of sedation to ease refractory 
symptoms at the end of life. 
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4.4. Conclusion 
Decision-making about continuous sedation goes through four stages and the involvement of the 
patient varies. Different conceptions of what sedation should be used for and how it should be 
practiced may have affected the role patients were given in the decision-making process. In 
order to be sensitive to a patientǯs individual preferences while at the same time acknowledging 
the potential sensitivity of raising the issue of continuous sedation until death with people who 
are dying, we recommend building into clinical practice opportunities to regularly discuss with 
them their goals and preferences regarding future medical care and treatment.  
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Table 1. Charles et al (24) model of treatment decision-making. 
 Paternalistic Shared decision-
making 
Informed 
Information exchange One-way: from doctor 
to patient, minimum 
necessary for 
informed consent. 
Two-way: doctor 
provides all medical 
information needed 
for decision-making, 
patient provides 
information about 
his/her preferences. 
One-way (largely): 
from doctor to 
patient, all medical 
information needed 
for decision-making. 
Deliberation Physician alone, or 
with other physicians.  
Physician and patient 
(plus potential 
others). 
Patient (plus 
potential others). 
Decision Physician. Physician and patient. Patient. 
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Table 2. Characteristics of patients. 
Characteristics United 
Kingdom 
Belgium The Netherlands Total 
Number of cases 7 7 10 24 
Age (years)     
<50 - 1 - 1 
51-60 2 2 2 6 
61-70 3 - 2 5 
71-80 2 3 5 10 
80+ - 1 1 2 
Gender     
Male 5 4 6 15 
Female 2 3 4 9 
Diagnosis     
adenocarcinoma - - 1 1 
abdominal / 
stomach 
- - 1 1 
bladder 1 - - 1 
Colon - 1 - 1 
facial maxillary 1 - - 1 
gall bladder 1 - - 1 
oesophageal - - 1 1 
leukaemia/ 
myelofibrosis/ 
myeloma 
- 2 - 2 
lung / 
mesothelioma 
- 1 3 4 
melanoma - 1 1 2 
pancreatic 1 - 1 2 
peritoneal 1 1 - 2 
prostate 1 - 1 2 
renal 
/hypernephroma 
1 1 - 2 
Unknown - - 1 1 
Care setting     
Home 3 3 4 10 
Hospital - 2 3 5 
Palliative Care Unit 
(BE)/hospice 
(UK/NL) 
4 2 3 9 
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Table 3. Characteristics of physicians, nurses and relatives. 
Characteristics Physicians (n= 26) Nurses (n=30) Relatives (n=24) 
Country UK (n= 9) BE (n= 7) NL (n= 
10) 
UK (n= 
10) 
BE (n= 10) NL(n= 10) UK (n= 7) BE (n= 7) NL (n= 10) 
Age (years)       N/A N/A N/A 
<40 5 2 3 1 4 6    
40-50 - 3 1 3 2 2    
51-60 - 2 5 1 4 2    
60+ - - 1 1 - -    
Not stated 4 - - 4 - -    
Gender          
Male 6 4 9 - 1 1 1 4 2 
Female 3 3 1 10 9 9 6 3 8 
Specialism          
Primary care 4 2 4 1 2 1 N/A N/A N/A 
Palliative home care team - 1 - 2 3 3    
Hospital oncology ward - - 2 - 2 2    
Palliative care 
unit/hospice care 
5 4 4 7 3 4    
Nature of relationship 
with patient 
N/A N/A N/A N/A N/A N/A    
Partner       4 4 6 
Child       3 2 2 
Sibling       - 1 1 
Parent       - - 1 
1 UK: United Kingdom; BE: Belgium; NL: The Netherlands 2 N/A: Not applicable 3 More than one could have been interviewed 4 Results from the relatives were identified by the 
relative that was identified by the physician as being the most involved. 
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Table 4. Characteristics of the decision-making process in the studied countries 1 
Stages United Kingdom (UK) The Netherlands Belgium 
1. Initiating the 
conversation 
A continuum with 
the initiative driven 
either by the patient 
or the physician. 
A continuum with 
the initiative driven 
either by the patient 
or the physician. 
Euthanasia was often 
the starting point of a 
conversation about 
end-of-life 
preferences and the 
possible use of 
sedation. 
A continuum with 
the initiative driven 
either by the patient 
or the physician. 
Euthanasia was often 
the starting point of a 
conversation about 
end-of-life 
preferences and the 
possible use of 
sedation. 
2. Information 
exchange 
The  physician 
usually took the lead 
providing all the 
necessary 
information to obtain 
informed consent of 
the patient and/or 
relatives 
The physician had 
rather an 
informative role, 
providing all medical 
information needed 
for decision-making, 
hoping to come to a 
shared decision by 
further exploring 
patient preferences. 
The physician mainly 
had an informative 
role, providing all 
medical information 
needed for decision-
making, hoping to 
come to a shared 
decision by further 
exploring patient 
preferences. 
3. Deliberation and 
the decision to use 
continuous sedation 
until death 
Usually discussed 
between the patient 
and those close to 
them. In case of 
disagreement, 
physician followed ǯǤ 
Usually discussed 
between the patient 
and those close to 
them. In case of 
disagreement, 
physician followed ǯǤ 
Usually discussed 
between the patient 
and those close to 
them. In case of 
disagreement, 
physician followed ǯǤ 
4. Decision phase Ȃ 
the moment to start 
continuous sedation 
until death 
A gradual 
progression without 
a particular moment 
of decision-making. 
Generally, a medical 
decision that 
physicians could take 
only if they felt that it 
was inevitable. 
When competent, in 
most cases either 
patient or the medical 
staff who took the 
final decision to start. 
When no longer 
competent, either 
family or the medical 
staff. 
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